ArticleBreast cancer research : BCR2026

Diagnostic plasma protein signatures in sporadic and BRCA1/2 breast cancer patients via targeted proteomics.

Kristrun Y Holm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.